| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | KIN001-055 | GDSC1000 | pan-cancer | AAC | 0.068 | 0.05 |
| mRNA | WZ4002 | CTRPv2 | pan-cancer | AAC | 0.087 | 0.05 |
| mRNA | Pazopanib | GDSC1000 | pan-cancer | AAC | 0.069 | 0.05 |
| mRNA | pifithrin-alpha | CTRPv2 | pan-cancer | AAC | 0.074 | 0.05 |
| mRNA | Z-LLNle-CHO | GDSC1000 | pan-cancer | AAC | 0.099 | 0.05 |
| mRNA | ZM-447439 | GDSC1000 | pan-cancer | AAC | -0.072 | 0.05 |
| mRNA | Crizotinib | gCSI | pan-cancer | AAC | 0.11 | 0.05 |
| mRNA | decitabine:carboplatin (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.055 | 0.05 |
| mRNA | Panobinostat | CTRPv2 | pan-cancer | AAC | -0.065 | 0.06 |
| mRNA | FTI-277 | GDSC1000 | pan-cancer | AAC | 0.066 | 0.06 |